ATA906481A - Verfahren zur herstellung eines praeparates von para-aroyl-phenoxy-isobuttersaeurederivaten - Google Patents

Verfahren zur herstellung eines praeparates von para-aroyl-phenoxy-isobuttersaeurederivaten

Info

Publication number
ATA906481A
ATA906481A AT0906481A AT906481A ATA906481A AT A906481 A ATA906481 A AT A906481A AT 0906481 A AT0906481 A AT 0906481A AT 906481 A AT906481 A AT 906481A AT A906481 A ATA906481 A AT A906481A
Authority
AT
Austria
Prior art keywords
aroyl
phenoxy
para
producing
preparation
Prior art date
Application number
AT0906481A
Other languages
English (en)
Other versions
AT387517B (de
Inventor
Claude Laruelle
Original Assignee
Claude Laruelle
Deshors Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Claude Laruelle, Deshors Sa filed Critical Claude Laruelle
Publication of ATA906481A publication Critical patent/ATA906481A/de
Application granted granted Critical
Publication of AT387517B publication Critical patent/AT387517B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT0906481A 1980-11-19 1981-11-18 Verfahren zur herstellung eines praeparates von para-aroyl-phenoxy-isobuttersaeurederivaten AT387517B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8024568A FR2494112B1 (de) 1980-11-19 1980-11-19

Publications (2)

Publication Number Publication Date
ATA906481A true ATA906481A (de) 1988-07-15
AT387517B AT387517B (de) 1989-02-10

Family

ID=9248140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0906481A AT387517B (de) 1980-11-19 1981-11-18 Verfahren zur herstellung eines praeparates von para-aroyl-phenoxy-isobuttersaeurederivaten

Country Status (8)

Country Link
EP (1) EP0065531A1 (de)
AT (1) AT387517B (de)
BE (1) BE891129A (de)
DE (1) DE3152519C2 (de)
FR (1) FR2494112B1 (de)
IT (1) IT1144948B (de)
NL (1) NL8120434A (de)
WO (1) WO1982001649A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
JPS60221078A (ja) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd 有用微生物粉末の粒状製品およびその製造法
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2737121B1 (fr) * 1995-07-27 1997-10-03 Cl Pharma Nouvelles formulations galeniques du fenofibrate et leurs applications
DE19608750A1 (de) * 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
DE19858789A1 (de) 1998-12-18 2000-06-21 Bayer Ag Kombination von Cerivastatin und Fibraten
US6368622B2 (en) 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
US6383517B1 (en) 1999-01-29 2002-05-07 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6180138B1 (en) 1999-01-29 2001-01-30 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
FR2819720B1 (fr) 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
AU2003263480A1 (en) * 2002-09-24 2004-04-19 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
CA2505521A1 (en) * 2002-11-22 2004-06-10 Meiji Seika Kaisha, Ltd. Granular composition and process for producing the same
EP1832285A1 (de) * 2002-12-17 2007-09-12 Abbott GmbH & Co. KG Formulierung mit Fenofibrinsäure oder einem physiologisch verträglichen Salz davon
CN101480384A (zh) * 2002-12-17 2009-07-15 阿伯特有限及两合公司 包含非诺贝酸、其生理可接受的盐或衍生物的制剂
EP1643975A2 (de) * 2003-07-02 2006-04-12 Abbott Laboratories Verfahren zur herstellung von formulierungen von lipid-regelnden arzneimitteln
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
EP1785133A1 (de) 2005-11-10 2007-05-16 Laboratoires Fournier S.A. Verwendung von Fenofibrate oder dessen Derivaten zur Prävention von diabetischer retinopathie
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2963402A (en) * 1955-01-18 1960-12-06 Nysco Lab Inc Sustained release medicament
FR1347413A (fr) * 1963-01-29 1963-12-27 Italnysco S P A Sphérules ou globules à action étalée et procédé pour leur préparation
GB1415295A (en) * 1971-10-14 1975-11-26 Orchimed Sa Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
ZA765931B (en) * 1975-10-10 1977-09-28 Squibb & Sons Inc Controlled release tablet
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
LU77353A1 (de) * 1977-05-16 1979-01-19
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention

Also Published As

Publication number Publication date
DE3152519T1 (de) 1983-12-29
WO1982001649A1 (fr) 1982-05-27
EP0065531A1 (de) 1982-12-01
AT387517B (de) 1989-02-10
FR2494112A1 (de) 1982-05-21
BE891129A (fr) 1982-05-17
DE3152519C2 (de) 1990-11-22
NL8120434A (nl) 1982-10-01
IT1144948B (it) 1986-10-29
IT8125185A0 (it) 1981-11-19
FR2494112B1 (de) 1986-01-10

Similar Documents

Publication Publication Date Title
AT387517B (de) Verfahren zur herstellung eines praeparates von para-aroyl-phenoxy-isobuttersaeurederivaten
AT362876B (de) Verfahren zur herstellung von 2-penem-3-carbonsaeureverbindungen
AT368168B (de) Verfahren zur herstellung von neuen thioetiansaeurederivaten
AT374785B (de) Verfahren zur herstellung von carbanilsaeure-c 1-4-alkylestern
AT382150B (de) Verfahren zur herstellung von neuen 3-amino-2-oxo-azetidin-1-sulfonsaeurederivaten
AT369744B (de) Verfahren zur herstellung von 6-beta-jod -penicillansaeure-derivaten
AT365209B (de) Verfahren zur herstellung von polymaleinsaeuren
AT379382B (de) Verfahren zur herstellung von neuen n-substituierten aziridin-2-carbonsaeurederivaten
AT370418B (de) Verfahren zur herstellung von derivaten der 7-aminothiazolylacetamidocephalosporansaeure
AT365564B (de) Verfahren zur herstellung von neuen alpha-phenylbenzylidenaminoalkansaeurederivaten
AT373230B (de) Verfahren zur herstellung von neuen estern von alkoxyalkanoylderivaten von carnitin
ATA51381A (de) Verfahren zur herstellung eines 1-/p-chlorbenzoyl)-5-methoxy-2-methyl-indol-3-y -essigsaeure nethaltendes arzneimittels
AT382151B (de) Verfahren zur herstellung von apovincaminsaeureester-derivaten
AT371469B (de) Verfahren zur herstellung von neuen penamcarbonsaeure-derivaten
ATA286683A (de) Verfahren zur herstellung von derivaten der 2-thiophenessigsaeure
AT376966B (de) Verfahren zur herstellung eines furanderivats
AT355216B (de) Verfahren zur herstellung von zubereitungs- formen von 3-n-pyrrolidino-4-phenoxy-5- sulfamyl-benzoesaeure
AT363594B (de) Verfahren zur herstellung eines neuen formamidkomplexes von 7-beta-(d-2-amino-2-phenylacetamido)-3-methylceph-3-emcarbonsaeure
AT374795B (de) Verfahren zur herstellung von neuen derivaten der pyrrol-2-essigsaeure
AT366694B (de) Verfahren zur herstellung von 6-betasubstituierten penicillansaeurederivaten
AT364355B (de) Verfahren zur herstellung von benzoxazolylpropionsaeurederivaten
ATA286783A (de) Verfahren zur herstellung von derivaten der 2-thiophenessigsaeure
ATA337083A (de) Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten
ATA219483A (de) Verfahren zur herstellung von 5-aroyl-1niederalkylpyrrol-2-essigsaeurederivaten
AT367756B (de) Verfahren zur herstellung von thiazolidin-4-on -essigsaeurederivaten

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee